Navigation Links
Northwest Biotherapeutics to Present at Next Generation Vaccine Conference
Date:7/17/2008

Highlights Include Clinical Trial Updates

BETHESDA, Md., July 18 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC Bulletin Board: NWBO), (the "Company or NWBT"), today announced that Dr. Alton L. Boynton, its President and Chief Executive Officer, will deliver a presentation updating the Company's progress in the development of dendritic vaccines for the treatment of cancer, at the "Next Generation Vaccines" conference. The conference will be held on 17 &18 July, at the Gaylord National Resort and Convention Center in National Harbor, Maryland, USA. Dr. Boynton is scheduled to present as part of the Advances in Cancer Vaccines session on July 18th @ 11:15 am EST.

Dr. Boynton will provide an update on NWBT's product candidates, including therapeutic cancer vaccines DCVax(R)-Brain for the treatment of Glioblastoma multiforme and DCVax(R)-Prostate for hormone-independent prostate cancer.

About Northwest Biotherapeutics

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products that treat cancers more effectively than current treatments, without toxicity, on a cost-effective basis. The Company has two broad platform technologies: dendritic cell-based vaccines and therapeutic antibodies. The Company is currently conducting a large Phase II clinical trial in GBM, which is designed and powered to serve as a pivotal trial. The Company has also received clearance from the FDA for a large Phase III trial in prostate cancer, and clearance from the FDA for Phase I trials in five other cancers. The Company has started a Phase I/II trial with DCVax(R) directed to ovarian cancer. The Company's second technology platform, involving antibodies to CXCR4, is at the late pre-clinical development stage.

For further information, please visit the company web site at http://www.nwbio.com

Statements made in th
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Northwestern chemist investigates lost reds in Homer painting
2. Nikon Instruments Opens New Imaging Center at Northwestern University
3. Northwest Secures US$4.0 Million in Debt Financing
4. Cell Therapeutics, Inc. (CTI) Invest Northwest Presentation to be Webcast
5. Cell Therapeutics, Inc. (CTI) to Present at 7th Annual WBBA Invest Northwest Conference
6. Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics
7. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
8. CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership
9. CardioVascular BioTherapeutics, Inc. Announces Update on Timing of Form 10-K Filing
10. Protalix BioTherapeutics Signs Lease Agreement for Expansion of its Manufacturing and Research Facility in Carmiel, Israel
11. Protalix BioTherapeutics Sets Record Date for Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2008)...STON, Oct. 11 /PRNewswire-USNewswire/ -- MedImmune... the American Academy of Pediatrics (AAP),2008 Nat...any,s growing,body of research into the prevention...ause of viral respiratory infection among preterm ...te the burden of RSV disease on,preterm babies, th...
(Date:10/10/2008)...MERYVILLE, Calif., Oct. 10 /PRNewswire-FirstCall/ ...sdaq: NTII ), today announced it will hold a,conf...pdate on the,Viprinex(TM) (ancrod) Phase 3 Trial P... will be Paul E. Freiman, president and chief exec...al officer., -- Date: Monday, October 13, 2008...
(Date:10/10/2008)...ORPUS CHRISTI, Texas, Oct. 10 /PRNewswire-FirstCal...: CTGI), a technology management,company, announce....S.,patent. The approval is on a key divisional ap...by Passing High Frequency Electric Current,Thereth...e Connects ("LTC"),platform tissue bonding/welding...
(Date:10/10/2008)...ANTA CLARA, Calif., Oct. 10 /- Finess...d control solutions for life science process,appli...eir E-Commerce Store,that makes shopping for senso...e found at the Finesse web site ( http://www.fines...chase bioprocess sensors and accessories,on-line, ...
Breaking Biology Technology:MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 2MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 3MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 4MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 5Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program 2CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved 2CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved 3
...ommon sense in project management isnt always so c...path-project scheduling, most projects are still l...ised. Whats the problem? What should we do? After ...,t enough time to complete it; that the estimates ...when you research and analyze the facts, the concl...
...ave endured a hard struggle, and somehow survived ...incipals failed. Now the same sites and domain nam...ensure high visibility and exposure. Today without...oomed. While billions of Web pages are poised for ... of surfing customers and simply flood each other....
...harter Business , a division of Charter Communica...lop its partnership with Berbee Information Netwo...ting Independent Pharmacy Cooperative (IPC) to B...ving to string together multiple T1 lines between ...hernet and provides the entire circuit themselves,...
... the UW-Madison College of Engineering, Dean Paul ...ring that todays engineering education includes wh...ly global environment. , ,At the University of Wis...System, a joint planning group is debating how to ...degrees and in what disciplines those degrees sho...
Other Biology Technology:Part 3 Project performance Get on the path to continuous improvement 2Part 3 Project performance Get on the path to continuous improvement 3The mysteries and the future of Web sites 2The mysteries and the future of Web sites 3The mysteries and the future of Web sites 4Charter and Berbee connect Pharmacy Cooperative 2Wisconsin must produce more science-savvy students to remain competitive 2Wisconsin must produce more science-savvy students to remain competitive 3
(Date:10/10/2008)...tors from the Herman B Wells Center for Pediatric ...ine are focusing on a family of blood proteins tha...ffects of chemotherapy in children and adults. ,...nt of targeted therapies for leukemia, multiple my...archers, led by Kristin T. Chun, Ph.D., assistant ...
(Date:10/10/2008)...ists have created nanowire sensors coupled with si...itive and specific enough to be used for point-of-...t in Nano Letters . , The sensors use activatio...natures of bacteria, viruses or cancer cells as t...uce acid, and generate a tiny current in the nanow...
(Date:10/9/2008)... /PRNewswire-FirstCall/ -- Synaptics(R),Incorporat...interface,solutions for mobile computing, communic... that it will report financial results for the fir... 2008 after the close of market. The,company will ...and,investors at 2:00 p.m. PT (5:00 p.m. ET) durin...
(Date:10/9/2008)... you have to worry about hungry starfish and even ...t can change your body temperature 50 degrees Fahr...ost variable habitats on Earth," said USC biologis...y bathed in cool Pacific seawater and the other pa... the first real-time molecular sampling of mussels...
Breaking Biology News(10 mins):On the trail of a targeted therapy for blood cancers 2Sensitive nanowire disease detectors made by Yale scientists 2Synaptics to Report First Quarter Results on October 23 2Brainy genes, not brawn, key to success on mussel beach 2Brainy genes, not brawn, key to success on mussel beach 3Women Deliver Conference Launches New Commitments 4207 1Women Deliver Conference Launches New Commitments 4207 2Fall Time Change Could Be Boon for Sleep 4204 1Fall Time Change Could Be Boon for Sleep 4204 2Youth and Health Experts Call on the Governor to Take the Buzz Out of Energy Drinks 4201 1Youth and Health Experts Call on the Governor to Take the Buzz Out of Energy Drinks 4201 2Pelosi Statement on Stark Comments 4198 1
...y comparing 140 sequenced bacterial genomes, resea...s essential to bacterial replication ?and they did.... , Mikhail Gelfand, a Howard Hughes Medical Inst...ute for Information Transmission Problems (IITP) i...onov, used comparative genomics to identify a new ...
... first-of-its-kind multi-center trial has shown th...hildren who suffered traumatic brain injury. , The... Pittsburgh neurosurgeon P. David Adelson, MD, and...te hypothermia initiated after severe traumatic br...n for children. , TBI initiates several metabolic...
...he 2004-2005 flu season was at least as severe as ...o data from Solucient, a leading provider of healt...ted the most recent flu season from being even wor...ital admissions for community-acquired pneumonia (...flu. Solucient analyzed CAP discharge data from Oc...
...esearch into a new treatment for nerve damage caus...iabetic patients, say experts. , The treatment mi...and feet if early effects on nerve protection and ...e in diabetes is the major cause of non-traumatic .... , Scientists at The University of Manchester, wo...
Other Biology News:Bioinformatics reveals new gene regulation system 2Bioinformatics reveals new gene regulation system 3Study Finds Moderate Hypothermia A Safe Treatment For Traumatic Brain Injury In Kids 2Diabetic nerve therapy shows 'striking' results 2
Lingo-1 (K-13)
HIF-1 beta (ARNT1) Purified Anti-Mouse, Anti-Rat, Anti-Human clone 29, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details.
MOUSE ANTI PORCINE SLA 1:FITC Immunogen: Porcine peripheral blood mononuclear cells.
An excellent carbonyl-reactive FRET quencher paired with Trp or Tyr. Minimum Purity: 95%. Abs(max): ~350 nm; Em(max): none. Solvent System:DMSO or DMF.
Biology Products: